| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 11 |
| 1 | CYCLOPHOSPHAMIDE | 7 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 4 | DOXORUBICIN | 6 |
| 5 | PREDNISOLONE | 5 |
| 6 | PREDNISOLONE ORAL | 5 |
| 7 | PREDNISOLONE ORAL SOLUTION | 5 |
| 8 | BORTEZOMIB | 3 |
| 9 | ENTECAVIR | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 1 | ENTECAVIR | 3 | 0.0003 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 2 | 0.0002 |
| 3 | DOFETILIDE | 2 | 0.0002 |
| 4 | DOXORUBICIN | 6 | 0.0001 |
| 5 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 2 | 0.0001 |
| 7 | RITUXIMAB | 11 | 0.0001 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 | 0.0000 |
| 9 | CYCLOPHOSPHAMIDE | 7 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 11 |
| 1 | Alkylating Drug [EPC] | 7 |
| 2 | Corticosteroid [EPC] | 6 |
| 3 | Antirheumatic Agent [EPC] | 3 |
| 4 | Interleukin-12 Antagonist [EPC] | 3 |
| 5 | Interleukin-23 Antagonist [EPC] | 3 |
| 6 | Proteasome Inhibitor [EPC] | 3 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 8 | Antiarrhythmic [EPC] | 2 |
| 9 | Interferon alpha [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 11 | 0.0000 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Interleukin-12 Antagonist [EPC] | 3 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 3 | 0.0000 |
| 6 | Proteasome Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Antiarrhythmic [EPC] | 2 | 0.0000 |
| 8 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |